Intervention

EndoBarrier Gastrointestinal Liner

ClinicalTrials.gov intervention label

Clinical trials5
Recruiting0
Common conditions2
Lead sponsors shown3

Clinical trials

5 shown
EndoBarrier Versus Intragastric Balloon in Obese Diabetic PatientsNCT01848795 · 2013-05-01
UNKNOWN
The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin HormonesNCT02360878 · 2013-02-01
COMPLETED
Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or ObesityNCT03072901 · 2010-12-01
TERMINATED
Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal LinerNCT01114438 · 2010-10-01
COMPLETED
A Study of the GI Sleeve for the Treatment of Type 2 DiabetesNCT02709577 · 2007-01-01
COMPLETED

Trial status mix

COMPLETED3
TERMINATED1
UNKNOWN1

Phase mix

NA1
PHASE11
PHASE21
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.